HeartSciences Inc. Receives FDA 510(k) Clearance for MyoVista wavECG Device

HeartSciences Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MyoVista wavECG device. The device integrates artificial intelligence to advance electrocardiography.